REQUEST A DEMO
Total
USD $0.00
Search more companies

Wuhan Hiteck Biological Pharma Co.,Ltd (武汉海特生物制药股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Wuhan Hiteck Biological Pharma Co.,Ltd Profile Updated: March 29, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Wuhan Hiteck Biological Pharma Co.,Ltd (武汉海特生物制药股份有限公司) is a company based in China, with its head office in Wuhan. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. The enterprise was incorporated on April 08, 1992. The total number of employees is currently 1,309 (2024). There was a net sales revenue drop of 7.84% reported in Wuhan Hiteck Biological Pharma Co.,Ltd (武汉海特生物制药股份有限公司)’s latest financial highlights for Q3C2025. Its’ total assets recorded a negative growth of 10.42%. The net profit margin of Wuhan Hiteck Biological Pharma Co.,Ltd (武汉海特生物制药股份有限公司) decreased by 29.35% in 2025.

Headquarters
Haite Science and Technology Park, Economic and Technological Development Zone, Wuhan City, Hubei Province
Wuhan; Hubei; Postal Code: 430056

Contact Details: Purchase the Wuhan Hiteck Biological Pharma Co.,Ltd (武汉海特生物制药股份有限公司) report to view the information.

Website: http://www.hiteck.com.cn

Basic Information
Total Employees:
Purchase the Wuhan Hiteck Biological Pharma Co.,Ltd (武汉海特生物制药股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Wuhan Hiteck Biological Pharma Co.,Ltd (武汉海特生物制药股份有限公司) report to view the information.
Registered Capital:
Purchase the Wuhan Hiteck Biological Pharma Co.,Ltd (武汉海特生物制药股份有限公司) report to view the information.
Financial Auditors:
Purchase the Wuhan Hiteck Biological Pharma Co.,Ltd (武汉海特生物制药股份有限公司) report to view the information.
Incorporation Date:
April 08, 1992
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
19.26%
Purchase this report to view the information.
11.3%
Purchase this report to view the information.
8.44%
Purchase this report to view the information.
2.29%
Purchase this report to view the information.
2.29%
Subsidiaries
Hainan Hanhe Pharmaceutical Co., Ltd
100%
Haite Biological (Xiamen) Co., Ltd.
100%
Hanrui Pharmaceutical (Jingmen) Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Wuhan Hiteck Biological Pharma Co.,Ltd (武汉海特生物制药股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-7.84%
Total Operating Revenue
-10.26%
Operating Profit
-282.53%
Net Profit/Loss for the Period
-281.25%
Total Assets
-10.42%
Total Equity
-8.54%
Operating Profit Margin
-34.45%
Net Profit Margin
-29.35%
Return on Equity (ROE)
-5.45%
Debt / Equity
2794%
Quick Ratio
586.42%
Cash Ratio
-0.82%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?